Paper683276
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.
Wanebo HJ and 6 others. N Engl J Med, 1978. Cited by 446 papers, by iCite.
Cite this record
ConductScience Library. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. Papers, record 683276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/683276
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoembryonic Antigen | Major topic |
| Colonic Neoplasms | Major topic |
| Rectal Neoplasms | Major topic |
| Humans | |
| Neoplasm Recurrence, Local | |
| Neoplasm Staging | |
| Prognosis | |
| Time Factors |
Source PubMed
Cited by129
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 446 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41851916 | Enhancing Cancer Prediction Among People With Elevated CEA: A Novel Approach Using CEA Levels and Clinical Risk Scoring. | J Prim Care Community Health | 2026 | https://conductscience.org/library/papers/41851916 | PubMed |
| 40960294 | Identification and predictive machine learning model construction of gut microbiota associated with carcinoembryonic antigens in colorectal cancer. | mSphere | 2025 | https://conductscience.org/library/papers/40960294 | PubMed |
| 38672639 | Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38672639 | PubMed |
| 37942534 | Detection and clinical significance of CEACAM5 methylation in colorectal cancer patients. | Cancer Sci | 2024 | https://conductscience.org/library/papers/37942534 | PubMed |
| 37761297 | Correlations between Demographic, Clinical, and Paraclinical Variables and Outcomes in Patients with KRAS-Mutant or KRAS Wild-Type Metastatic Colorectal Cancer-A Retrospective Study from a Tertiary-Level Center in Romania. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37761297 | PubMed |
| 37302022 | Cell-free circulating ALU repeats in serum have a prognostic value for colorectal cancer patients. | Cancer Biomark | 2023 | https://conductscience.org/library/papers/37302022 | PubMed |
| 36945303 | Clinical study of colorectal cancer operation: Survival analysis. | Korean J Clin Oncol | 2020 | https://conductscience.org/library/papers/36945303 | PubMed |
| 36562938 | Circulating Tumor DNA: Towards More Individualized Treatment for Patients with Resectable Colorectal Cancer. | J Gastrointest Cancer | 2023 | https://conductscience.org/library/papers/36562938 | PubMed |
| 36418865 | The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer. | Sci Rep | 2022 | https://conductscience.org/library/papers/36418865 | PubMed |
| 35884455 | Type IV Collagen in Human Colorectal Liver Metastases-Cellular Origin and a Circulating Biomarker. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35884455 | PubMed |
| 34066954 | ΔNp73, TAp73 and Δ133p53 Extracellular Vesicle Cargo as Early Diagnosis Markers in Colorectal Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34066954 | PubMed |
| 33971705 | Prognostic Impact of Carcinoembryonic Antigen Levels in Rectal Cancer Patients Who Had Received Neoadjuvant Chemoradiotherapy. | Ann Coloproctol | 2021 | https://conductscience.org/library/papers/33971705 | PubMed |
| 33397889 | Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. | Nat Commun | 2021 | https://conductscience.org/library/papers/33397889 | PubMed |
| 33335852 | A Novel Prognostic Model Incorporating Carcinoembryonic Antigen in 3-Week or Longer Postoperative Period for Stage III Colon Cancer: A Multicenter Retrospective Study. | Front Oncol | 2020 | https://conductscience.org/library/papers/33335852 | PubMed |
| 32972104 | Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer. | Ann Coloproctol | 2021 | https://conductscience.org/library/papers/32972104 | PubMed |
| 32612370 | Differential Metabolic Alterations and Biomarkers Between Gastric Cancer and Colorectal Cancer: A Systematic Review and Meta-Analysis. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32612370 | PubMed |
| 31937069 | A Review of the Role of Carcinoembryonic Antigen in Clinical Practice. | Ann Coloproctol | 2019 | https://conductscience.org/library/papers/31937069 | PubMed |
| 31916018 | Different variables predict the outcome of patients with synchronous versus metachronous metastases of colorectal cancer. | Clin Transl Oncol | 2020 | https://conductscience.org/library/papers/31916018 | PubMed |
| 31278528 | Common habitual behaviors and synchronous colorectal cancer risk: a retrospective case-control study. | Int J Colorectal Dis | 2019 | https://conductscience.org/library/papers/31278528 | PubMed |
| 31167699 | Unrecognized Value of Carcinoembryonic Antigen in Recurrent Rectal and Sigmoid Colon Cancer: Case Series. | Perm J | 2019 | https://conductscience.org/library/papers/31167699 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/683276
GET https://conductscience.org/api/papers/v1/683276/cited_by?page=2